Literature DB >> 8056721

Purification of cardiac annexin V from the beagle dog heart and changes in its localization in the ischemic rat heart.

N Kaneko1, R Matsuda, F Chiwaki, S Hosoda.   

Abstract

We isolated and purified 35 kDa protein from the myocardium of the beagle dog and identified it to be annexin V from partial amino acid sequence determination. It was confirmed that anticanine cardiac annexin V rabbit polyclonal antibody, which was produced using the 35 kDa protein, cross-reacts with annexin V of the myocardium, lung, liver, kidney, and brain of the rat. The localization of cardiac annexin V and the effect of ischemia for 30-180 min in the rat were immunohistochemically studied with the use of the Langendorff perfusion heart. In the normal myocardium, annexin V, accompanied by cross-striation, was observed throughout the cell. In ischemia of 30 min, extracellular leakage of annexin V was observed with uneven staining in the cytoplasm. When the ischemic time exceeded 60 min, annexin V was observed in the cell membrane with a decrease of annexin V in the cytoplasm. Also, extracellular leakage of annexin V was observed prominently. In ischemia for 180 min, almost all the annexin V in the cytoplasm disappeared. These results suggest that the level of ischemia can be estimated from the changes in localization of annexin V.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056721     DOI: 10.1007/bf01745240

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

Review 1.  Annexins--new family of Ca2+-regulated-phospholipid binding protein.

Authors:  M J Geisow; J H Walker; C Boustead; W Taylor
Journal:  Biosci Rep       Date:  1987-04       Impact factor: 3.840

2.  Cloning and expression of cDNA for human endonexin II, a Ca2+ and phospholipid binding protein.

Authors:  R Kaplan; M Jaye; W H Burgess; D D Schlaepfer; H T Haigler
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

3.  Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids.

Authors:  C P Reutelingsperger; J M Kop; G Hornstra; H C Hemker
Journal:  Eur J Biochem       Date:  1988-04-05

4.  Common domain structure of Ca2+ and lipid-binding proteins.

Authors:  M J Geisow
Journal:  FEBS Lett       Date:  1986-07-14       Impact factor: 4.124

5.  Primary structure of human placental anticoagulant protein.

Authors:  T Funakoshi; L E Hendrickson; B A McMullen; K Fujikawa
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

6.  Five distinct calcium and phospholipid binding proteins share homology with lipocortin I.

Authors:  R B Pepinsky; R Tizard; R J Mattaliano; L K Sinclair; G T Miller; J L Browning; E P Chow; C Burne; K S Huang; D Pratt
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

7.  Differentiation of HL-60 cells is associated with an increase in the 35-kDa protein lipocortin I.

Authors:  F William; B Mroczkowski; S Cohen; A S Kraft
Journal:  J Cell Physiol       Date:  1988-12       Impact factor: 6.384

8.  Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins.

Authors:  R A Blackwood; J D Ernst
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

9.  Identification and immunolocalisation of annexins V and VI, the major cardiac annexins, in rat heart.

Authors:  A F Doubell; C Lazure; C Charbonneau; G Thibault
Journal:  Cardiovasc Res       Date:  1993-07       Impact factor: 10.787

10.  Ca(2+)-dependent phospholipid and arachidonic acid binding by the placental annexins VI and IV.

Authors:  H C Edwards; M J Crumpton
Journal:  Eur J Biochem       Date:  1991-05-23
View more
  1 in total

1.  The effect of K201 on isolated working rabbit heart mechanical function during pharmacologically induced Ca2+ overload.

Authors:  A Kelly; E B Elliott; R Matsuda; N Kaneko; G L Smith; C M Loughrey
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.